Filing Details

Accession Number:
0001382963-17-000166
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-27 13:49:55
Reporting Period:
2017-10-03
Accepted Time:
2017-10-27 13:49:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1460702 Ritter Pharmaceuticals Inc RTTR Pharmaceutical Preparations (2834) 263474527
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1493269 Javelin Venture Partners, L.p. One Rincon Center
101 Spear Street, Suite 255
San Francisco CA 94105
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-03 5,000,000 $0.00 7,047,804 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (right to buy) Acquisiton 2017-10-03 5,000,000 $0.00 5,000,000 $0.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000,000 2017-10-03 2022-10-03 No 4 P Direct
Footnotes
  1. The Reporting Person purchased 5,000,000 Class A Units of the Issuer, consisting of 5,000,000 shares of common stock and warrants to purchase 5,000,000 shares of common stock, in the Issuer's October 2017 public offering at the public offering price of $0.40 per Class A Unit. The shares of common stock and warrants that are part of the Class A Units sold to the Reporting Person in the puble offering were immediately separable and were issued separately in the offering.